ArticleOncotarget2018
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib.
Paola Queirolo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleOncotarget2018
Paola Queirolo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.